ORIGINAL ARTICLE |
|
Year : 2015 | Volume
: 9
| Issue : 3 | Page : 272-278 |
|
Effectiveness of intravenous infusion of N-acetylcysteine in cirrhotic patients undergoing major abdominal surgeries
Eman Sayed Ibrahim1, Ahmed Sharawy2
1 Department of Anesthesia, National Liver Institute, Menofeya University, Menofeya, Egypt 2 Department of Clinical Pathology, National Liver Institute, Menofeya University, Menofeya, Egypt
Correspondence Address:
Dr. Eman Sayed Ibrahim 18 Hassan Abdel Latif, Maleka, Fesal, Giza Egypt
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1658-354X.154706
|
|
Background: Postoperative acute kidney injury (AKI) is common in patients with chronic liver disease. We prospectively evaluated effectiveness of the N-acetylcysteine (NAC) in preserving postoperative renal functions in cirrhotic patients undergoing major abdominal surgeries. Materials and Methods: A total of 60 cirrhotic patients child A to B were randomized into two groups of 30 each.NAC groupwas received intravenous infusion of NAC (1200 mg/12h starting immediately before surgery and continued for 72h h postoperative) and controls group received a similar volume of glucose 5% solution as a a placebo. Systemic hemodynamics, hepatic and renal functions, serum cystatin C and cystatin C glomerular filtration rate (GFR) (GFR) were compared between both groups. Results: Serum level of cystatin C was raised significantly above the basal value at postoperative day 1 and day 3 associated with significantly decreased in cystatin C GFR below the basal value in the control group (P = 0.001). 6 (20%) (PP = 0.03) in control group developed AKI based on cystatin C GFR criteria (GFR <55 ml/min/1.73m 2 ). Mean values of alanine aminotransferase and aspartate aminotransferase were increased significantly above the basal values in both groups, but the increases were significantly lower in NAC group (P = 0.00). Chest infection was significantly lower associated with shorter hospital stay in the NAC group than the control group. Conclusion: Intravenous administration of NAC NAC in cirrhotic patients undergoing major abdominal surgeries reduces the incidence of cystatin C GFR-based AKI, postoperative renal and liver functions were well-preserved and improved outcome. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|